Raloxifene contraindications

List of contraindications
Invasive breast cancer Noninvasive breast cancer Pregnancy Venous thromboembolic events Allergy Coadministration

Treatment of invasive breast cancer
Raloxifene is not indicated for the treatment of invasive breast cancer or reduction of the risk of recurrence. Return to top

Noninvasive breast cancer
Raloxifene is not indicated for the reduction in the risk of noninvasive breast cancer. Return to top

Pregnancy
Raloxifene is contraindicated in women who are or may become pregnant and in nursing mothers. Return to top

Venous thromboembolic events
Raloxifene should not be administered to women with active or history of venous thromboembolic events, including deep venous thrombosis, pulmonary embolism, and retinal vein thrombosis. Return to top

Allergy
Raloxifene is not indicated for patients with an allergy to raloxifene or other constituents of the tablet. Return to top

Coadministration
Raloxifene is contraindicated with coadministration of cholestyramine. Return to top